Medtronic (MDT) Tops Q2 EPS by 2c; Guides FY23 EPS Below the Street
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Medtronic dips on miss and lower guidance from slow procedure and supply recovery
November 22, 2022 9:01 AM ESTMedtronic (NYSE: MDT) fell nearly 5% in pre-open trading Tuesday following a miss on the top-line for the second quarter and lower full-year guidance.
The medical device maker reported that revenue fell 3% to $7.6 billion, missing the Wall Street consensus of $7.7 billion. The company said the results reflect "slower supply recovery or lower than anticipated underlying market procedure volumes in certain businesses and... More
